KR20010025540A - Processing method of functional salt involved mulberry leaves - Google Patents
Processing method of functional salt involved mulberry leaves Download PDFInfo
- Publication number
- KR20010025540A KR20010025540A KR1020010000279A KR20010000279A KR20010025540A KR 20010025540 A KR20010025540 A KR 20010025540A KR 1020010000279 A KR1020010000279 A KR 1020010000279A KR 20010000279 A KR20010000279 A KR 20010000279A KR 20010025540 A KR20010025540 A KR 20010025540A
- Authority
- KR
- South Korea
- Prior art keywords
- mulberry leaf
- salt
- leaf powder
- mulberry
- mulberry leaves
- Prior art date
Links
- 240000000249 Morus alba Species 0.000 title claims abstract description 34
- 235000008708 Morus alba Nutrition 0.000 title claims abstract description 34
- 150000003839 salts Chemical class 0.000 title claims abstract description 33
- 238000003672 processing method Methods 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 9
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910001873 dinitrogen Inorganic materials 0.000 claims abstract description 3
- 239000002245 particle Substances 0.000 claims abstract 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 4
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 230000002490 cerebral effect Effects 0.000 abstract description 2
- 238000001816 cooling Methods 0.000 abstract description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 abstract description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 abstract description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 abstract description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 abstract description 2
- 235000005493 rutin Nutrition 0.000 abstract description 2
- 229960004555 rutoside Drugs 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 18
- 235000012000 cholesterol Nutrition 0.000 description 8
- 206010020772 Hypertension Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 235000015598 salt intake Nutrition 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- RQPUBRCMWBQELA-UHFFFAOYSA-N [K].[Fe].[Ca] Chemical compound [K].[Fe].[Ca] RQPUBRCMWBQELA-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- -1 chlorine ions Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
심혈관계 질환(cardiovascular disease, CVD)은 최근 한국인의 주요 사망요인으로 대두되고 있는 만성 퇴행성 질환으로 이중 고혈압은 원인은 확실하지 않으나 환경적인 인자와 유전적 요인에 의한 것으로 알려져 있다. 환경인자 가운데 식생활이 차지하는 비율이 높은데 우리 나라 사람들의 식이인자중에서 높은 소금의 섭취량이 주된 요인으로 지적되고 있다. 이와 같이 소금의 섭취는 모자라도 좋지 않고 지나쳐도 좋지 않다고 할 정도로 인체의 기본적인 필수 성분이다. 그러나 소금 섭취량이 많은 경우에는 고혈압과 같은 성인병의 원인으로 작용하기도 한다. 본 발명은 소금 속에 함유된 나트륨의 체내에서의 흡수율을 줄이고 소금의 섭취와 더불어 기능성 요소의 섭취를 위한 방법으로 뽕잎을 이용하여 기능성 소금을 제조하는 방법에 관한 것이다. 구체적으로는 혐기처리한 뽕잎파우더와 에탄올을 이용하여 추출한 뽕잎 추출액을 사용하여 기능성 소금을 제조하는 기술이다.Cardiovascular disease (CVD) is a chronic degenerative disease that has recently emerged as the leading cause of death in Koreans. Hypertension is unknown due to environmental and genetic factors. The dietary portion of the environmental factors is high, the high salt intake among the dietary factors of our people is pointed to be the main factor. In this way, the consumption of salt is not good enough, or too good to be overlooked is a basic essential component of the human body. However, when the salt intake is high, it may also act as a cause of adult diseases such as high blood pressure. The present invention relates to a method for producing functional salts using mulberry leaves as a method for reducing the absorption rate of sodium contained in the salt in the body and the intake of functional elements together with the salt intake. Specifically, it is a technique for preparing a functional salt using the mulberry leaf extract extracted using anaerobic mulberry leaf powder and ethanol.
성인이 하루에 필요로 하는 미네랄성분의 필요량이 300mg인데 가정에서 조리용으로 사용되는 소금의 양은 15g 정도로 여기에서 섭취할 수 있는 미네랄의 양은 8∼9 mg 정도에 지나지 않아서 소금으로부터 미네랄 성분을 충분히 공급받는다는 것은 기대하기 어렵다. 또한 소금 중에 함유된 나트륨 성분에 의하여 혈압증가의 원인이 되어 고혈압 환자가 섭취하기에 적당하지 않다고 할 수 있다. 이러한 문제점을 해결하기 위하여 본 발명에서는 나트륨과 체내에서 길항작용을 하는 갈륨을 비롯한 다수의 미네랄이 풍부하며, 혈당강하 효과와 혈압을 안정적으로 유지하는데 효과가 좋은 뽕잎을 이용하여 기능성 소금을 제조하고자 한다. 뽕잎에는 표 1에서 보는바와 같이 칼륨과 칼슘 그리고 철분을 비롯한 50여종 이상의 미네랄이 풍부하게 함유되어 있다.Adults need 300mg of minerals a day, but the amount of salt used for cooking at home is about 15g, and the amount of minerals that can be consumed here is only 8-9mg, so the minerals are supplied sufficiently from salt. Receiving is hard to expect. In addition, the sodium content in salt causes blood pressure to increase, which is not suitable for hypertension patients. In order to solve this problem, the present invention is rich in a number of minerals, including sodium and gallium, which antagonizes the body, and intends to produce functional salts using mulberry leaves which are effective in maintaining blood sugar lowering effect and blood pressure stably. . Mulberry leaves are rich in more than 50 minerals, including potassium, calcium and iron, as shown in Table 1.
표 1. 뽕잎의 성분비교(마른 잎 100g중 mg)Table 1.Comparison of Ingredients in Mulberry Leaves (mg in 100g of dried leaves)
즉, 뽕잎에는 무와 비교하여 보면 뼈를 튼튼하게 해주고 골다공증을 예방하는 칼슘은 60배, 피의 원료가 되는 철분은 160배 가 함유되어 있고, 뇌혈관을 튼튼하게 해주는 루틴(Rutin)이 메밀보다 18배나 많으며, 혈압을 낮춰주는 가바(GABA)의 함량이 높은 고 기능성 식품이라고 할 수 있다. 뽕잎은 고혈압 환자들의 혈압을 저하하고 안정화하며, 혈중의 중성지방 농도와 콜레스테롤의 함량을 저하시키며 특히 이로운 고밀도 콜레스테롤 (HDL-cholesterol)치는 높여주고 해로운 저밀도 콜레스테롤 (LDL-cholesterol) 치는 낮춰주는 효과를 보였다. 이와 같이 뽕잎은 노화를 억제하고 문화병, 현대인의 성인이 갖는 갖가지 성인병의 발생을 억제하면서 치료제로서의 가능성을 보여주고 있다. 따라서 이러한 특징을 지닌 뽕잎이 첨가된 소금이 제조되면 소금에서 부족한 미네랄을 충분히 섭취할 수 있으며, 소금의 섭취에 따라 문제시되고 있는 고혈압의 예방에 탁월한 효과가 있을 것으로 판단된다.In other words, compared to radish, mulberry leaves contain 60 times more calcium, which prevents osteoporosis, and 160 times more iron, which is the source of blood, and 18 times stronger than buckwheat. It is a high functional food with a high content of GABA that lowers blood pressure. Mulberry leaves have been shown to lower and stabilize blood pressure in hypertensive patients, lower triglyceride levels and cholesterol levels in blood, increase high levels of beneficial HDL-cholesterol and lower levels of harmful low density cholesterol (LDL-cholesterol). . As such, mulberry leaves have shown potential as a therapeutic agent while suppressing aging and suppressing the occurrence of various diseases of cultures and adults of modern people. Therefore, when the salt is added to the mulberry leaf having such characteristics can be enough to consume enough minerals from the salt, it is believed that it will have an excellent effect on the prevention of high blood pressure, which is a problem according to the intake of salt.
이와 같은 발명을 달성하기 위하여 뽕잎이 인체에 미치는 영향을 분석하고 이를 바탕으로 뽕잎을 첨가한 기능성소금을 제조하였다.In order to achieve the above invention, the effect of mulberry leaves on the human body was analyzed and functional salts were added based on the mulberry leaves.
< 실시 예 1 ><Example 1>
에탄올을 이용하여 뽕잎성분을 추출하여 추출물이 고지혈증 휜 쥐의 간 중량변화와 콜레스테롤 농도에 미치는 영향을 분석하여 그 결과를 표 2에 나타내었다.Extracting mulberry leaves using ethanol to analyze the effect of the extract on liver weight change and cholesterol concentration of hyperlipidemic rats are shown in Table 2.
표 2. 고지혈증이 유도된 휜 쥐의 간 무게에 미치는 뽕잎추출물의 영향Table 2. Effect of Mulberry Leaf Extract on Liver Weight of Hyperlipidemia-Induced Rats
고지혈증 유도군에 뽕잎추출물을 투여한 경우 고지혈증 유도군에 비하여 총콜레스테롤중에 고밀도콜레스테롤이 차지하는 비중이 증가하는 사실로 부터, 뽕잎성분은 단순한 고지혈증 억제작용뿐만 아니라 각종 동맥경화 현상을 예방할 수 있다는 사실을 확인하였다.When the mulberry leaf extract was administered to the hyperlipidemic group, the proportion of high-density cholesterol in the total cholesterol increased compared to the hyperlipidemic group. It was.
< 실시 예 2 ><Example 2>
천일염 중에 들어있는 염소이온(Cl)과 황산이온(SO4)이 함유된 유해성 성분을 제거하기 위하여 300∼400℃에서 1시간동안 열처리한 후 자연 냉각시키고 여기에 질소가스를 주입하는 혐기처리공정에 의하여 처리한 뽕잎을 건조 후 파쇄하여 제조한 뽕잎분말을 교반형 반응기에 소금과 함께 혼합하여 뽕잎이 첨가된 소금을 제조하였다.In order to remove harmful components containing chlorine ions (Cl) and sulfate ions (SO 4 ) in sun salt, heat treatment at 300 ~ 400 ℃ for 1 hour, then naturally cool and inject anaerobic treatment into nitrogen gas. The mulberry leaf powder, which was treated by drying, and then crushed, was mixed with salt in a stirred reactor to prepare a salt with added mulberry leaves.
< 실시 예 3 ><Example 3>
천일염 중에 들어있는 염소이온(Cl)과 황산이온(SO4)이 함유된 유해성 성분을 제거하기 위하여 300∼400℃에서 1시간동안 열처리한 후 자연 냉각시키고 여기에 에탄올을 이용하여 추출한 뽕잎 추출액과 냉각된 소금을 반응기의 상단에서 분산형태로 혼합반응기에 주입하여 뽕잎 추출액이 부착된 소금을 제조하였다.In order to remove harmful components containing chlorine ion (Cl) and sulfate ion (SO 4 ) in sun salt, heat-treated at 300 ~ 400 ℃ for 1 hour, and then naturally cooled and mulberry leaf extract extracted with ethanol and cooling The prepared salt was injected into the mixed reactor in a dispersed form at the top of the reactor to prepare a salt to which the mulberry leaf extract was attached.
뇌혈관을 튼튼하게 해주는 루틴(Rutin)과 혈압을 낮춰주는 가바(GABA)의 함량이 높은 뽕잎을 이용하여 제조된 소금은 고혈압 환자들의 혈압을 저하하고 안정화하며, 혈중의 중성지방 농도와 콜레스테롤의 함량을 저하시키며 특히 이로운 고밀도 콜레스테롤을 높이는 효과에 의하여 성인이 갖는 갖가지 성인병의 발생을 억제하면서 소금에서 부족한 미네랄을 충분히 섭취할 수 있으며, 소금의 섭취에 따라 문제시되고 있는 고혈압의 예방에 탁월한 효과가 있을 것으로 기대된다.Salt prepared by using a mulberry leaf with a high content of rutin, which strengthens the cerebral blood vessels, and GABA, which lowers blood pressure, lowers and stabilizes the blood pressure of hypertensive patients, and the level of triglycerides and cholesterol in the blood. It is possible to consume enough minerals from salts while suppressing the occurrence of various adult diseases that adults have, due to the effect of increasing high-density cholesterol, which is beneficial, and has an excellent effect in preventing high blood pressure, which is a problem caused by salt intake. It is expected.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010000279A KR20010025540A (en) | 2001-01-04 | 2001-01-04 | Processing method of functional salt involved mulberry leaves |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010000279A KR20010025540A (en) | 2001-01-04 | 2001-01-04 | Processing method of functional salt involved mulberry leaves |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20010025540A true KR20010025540A (en) | 2001-04-06 |
Family
ID=19704242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020010000279A KR20010025540A (en) | 2001-01-04 | 2001-01-04 | Processing method of functional salt involved mulberry leaves |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20010025540A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020080814A (en) * | 2001-04-17 | 2002-10-26 | 이성문 | Health foods based on bio fresh salt and manufacturing method thereof |
KR101140156B1 (en) * | 2009-07-02 | 2012-05-02 | (주)죽력원 | Method for manufacturing functional salt using mulberry leaves |
KR101404204B1 (en) * | 2012-11-06 | 2014-06-09 | 이승구 | Method of manufacturing mulberry salt |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970019892A (en) * | 1995-10-05 | 1997-05-28 | 이성문 | Manufacturing method of health food based on fresh salt |
KR19980083004A (en) * | 1997-05-10 | 1998-12-05 | 이성문 | Healthy powder and preparation method thereof |
KR20000007544A (en) * | 1998-07-04 | 2000-02-07 | 이성문 | Healthy food made by bamboo salt as main material and production method thereof |
JP2000281583A (en) * | 1999-03-26 | 2000-10-10 | Gotoo Corporation:Kk | Health auxiliary preparation containing leaf of mulberry and health auxiliary beverage and food |
-
2001
- 2001-01-04 KR KR1020010000279A patent/KR20010025540A/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970019892A (en) * | 1995-10-05 | 1997-05-28 | 이성문 | Manufacturing method of health food based on fresh salt |
KR19980083004A (en) * | 1997-05-10 | 1998-12-05 | 이성문 | Healthy powder and preparation method thereof |
KR20000007544A (en) * | 1998-07-04 | 2000-02-07 | 이성문 | Healthy food made by bamboo salt as main material and production method thereof |
JP2000281583A (en) * | 1999-03-26 | 2000-10-10 | Gotoo Corporation:Kk | Health auxiliary preparation containing leaf of mulberry and health auxiliary beverage and food |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020080814A (en) * | 2001-04-17 | 2002-10-26 | 이성문 | Health foods based on bio fresh salt and manufacturing method thereof |
KR101140156B1 (en) * | 2009-07-02 | 2012-05-02 | (주)죽력원 | Method for manufacturing functional salt using mulberry leaves |
KR101404204B1 (en) * | 2012-11-06 | 2014-06-09 | 이승구 | Method of manufacturing mulberry salt |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102228121A (en) | Method for preparing coffee reaction flavor through Maillard reaction and application of coffee reaction flavor | |
CN104824693A (en) | Preparation method for special lamb chop with health effect | |
KR101140156B1 (en) | Method for manufacturing functional salt using mulberry leaves | |
CN112568352A (en) | Anti-oxidation beauty-maintaining and young-keeping mulberry and lycium ruthenicum solid beverage and preparation method thereof | |
KR101264245B1 (en) | Functional fermented food for improvement of gout | |
KR20010025540A (en) | Processing method of functional salt involved mulberry leaves | |
CN104739977A (en) | Maca health wine/tablet with function of strengthening primordial qi | |
CN106396504A (en) | Multifunctional indoor decoration material, and preparation method thereof | |
CN101491279B (en) | Mid-aged formula milk powder and preparation method thereof | |
CN106562110A (en) | Chinese herbal medicinal feed additive composition for salvelinus malma and preparation method and use thereof | |
CN109897986A (en) | A kind of health care composite material and preparation method | |
KR101237218B1 (en) | Health-aid food composition including gall bladder of frog and manufacturing method of thereof | |
KR20090129765A (en) | Mineral fortified salt and manufacturing method thereof | |
KR100815195B1 (en) | The manufacturing method of raw wine containing wormwood | |
CN109463614B (en) | Protective agent for high-stability gardenia yellow pigment, preparation process and coloring process of high-stability gardenia yellow pigment | |
CN105754374A (en) | Preparation method of high-stability food-grade red pigment | |
KR20020032668A (en) | A method for manufacturing aloe added alcoholic liguors | |
KR101187806B1 (en) | Method for producing salt using extracting oil of bamboo and salt using extracting oil of bamboo manufactured thereof | |
KR102390894B1 (en) | Functional salt comprising red gensing and sericite and method thereof | |
CN109122984A (en) | A kind of discharging and youth keeping tea and preparation method thereof | |
KR100749143B1 (en) | Method for manufacturing of powder of low salted japanese anchovy by using of plum | |
CN108477359A (en) | A kind of cucurbit tea-drinking and preparation method thereof | |
CN115769886A (en) | Fire-clearing type pepper additive and preparation process thereof | |
JP7148680B2 (en) | Composition for reducing blood nicotine level and method for producing the same | |
CN116813306B (en) | Preparation method of enamel-free health-preserving black sand marmite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |